 |
|
 |
 |

Home > Company Index > Health Products & Services > Medical Laboratories & Research > Celeris Corporation
 |
Celeris Corporation |
 |
 |
 |
PROFILE |
 |
Celeris helps companies get FDA approval for new drugs and medical products with more celerity. The firm provides regulatory consulting, clinical research, and clinical trial management services to companies in the biotechnology, pharmaceutical, and medical device industries. Through subsidiary C. L. McIntosh & Associates, the company helps product manufacturers seek FDA approval and comply with FDA regulations. The company also evaluates medical equipment, performs quality assurance testing, and monitors clinical trials. A division of drugmaker Roche accounts for more than a quarter of sales. Celeris previously developed and sold software for the health care industry, but exited that business in 1998.
COMPETITION |
 |
Covance Inc. (CVD)
PAREXEL International Corporation (PRXL)
Quintiles Transnational Corp. (QTRN)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 11.20
1-Yr. Sales Growth: 20.4%
Employees: 89
Revenue per employee: $125,842.70
KEY PEOPLE |
 |
Barbara A. Cannon
CEO
Paul R. Johnson
CFO
CONTACT INFO |
 |
1801 West End Ave.
Nashville, TN 37203
US
Phone: 615-341-0223
Fax: 615-341-0258
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |